TNF, Toll-like receptor, NF-κB, and MyD88 pathways

The phrase combines multiple essential players in the immune and inflammatory response network: - **Tumor necrosis factor (TNF)** is a pro-inflammatory cytokine that binds TNF receptors to trigger cell death and inflammatory cascades[7]. - **Toll-like receptors (TLRs)** are **pattern recognition receptors** that detect pathogen-associated molecular patterns and initiate innate immunity[1][2][3][4]. - **NF-κB** is a **transcription factor** central to inflammatory gene regulation, activated downstream of both TNF receptor and TLR pathways via distinct adaptors and kinases[4][5][6]. - **MyD88** is the **primary adaptor** for most TLRs (except TLR3), linking pathogen detection to activation of **NF-κB** and other inflammatory pathways[2][3][6]. Each component is a validated or investigational drug target in immunology, oncology, and infectious disease. However, as written, the entry does not refer to a uniquely defined molecular target and should be **deconstructed into its individual components for proper database structuring**[1][2][3][4][5][6][7].

Inhibition of cytokine or receptor-ligand binding (e.g., TNF inhibitors). Blockade of adaptor protein interaction (e.g., MyD88 inhibitors). Transcriptional inhibition of NF-κB targets. Activation or inhibition of TLRs to modulate immune response.